SCHEMBL31003370

SCHEMBL31003370

COCc1nc(C#N)ccc1C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 1/20 0.40
ALDH1A1 P00352 8/20 0.38
MAPT P10636 3/20 0.38
HTT P42858 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
KDM4E B2RXH2 9/20 0.37
MAPK1 P28482 2/20 0.37
HPGD P15428 7/20 0.37
GAA P10253 3/20 0.37
HSD17B10 Q99714 5/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
SOS2 Q07890 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
APOBEC3G Q9HC16 2/20 0.34
ALOX15 P16050 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.33
POLB P06746 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30403774 0.81 NQO1 (0.39) NQO1ALDH1A1KDM4EMAPK1MEN1
SCHEMBL2963112 0.81 NQO1 (0.39) NQO1ALDH1A1KDM4EMAPK1MEN1
SCHEMBL24141592 0.79 MEN1 (0.41) NQO1ALDH1A1MAPTHTTKDM4E
SCHEMBL2959300 0.79 ALDH1A1 (0.38) NQO1ALDH1A1MAPTKDM4EHSD17B10
SCHEMBL31088161 0.78 NQO1 (0.35) NQO1ALDH1A1MEN1KMT2ASOS2
SCHEMBL2960636 0.78 NQO1 (0.35) NQO1ALDH1A1MEN1KMT2ASOS2
SCHEMBL23565835 0.72 HTR2A (0.33) NQO1SOS2
SCHEMBL16835564 0.72 KDM4E (0.39) NQO1ALDH1A1MAPTKDM4EHPGD
SCHEMBL31546853 0.72 TUBB4A (0.40) ALDH1A1MAPTKDM4EHPGDPOLB
SCHEMBL19144947 0.72 NQO1 (0.47) NQO1ALDH1A1KDM4EMAPK1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4658656-A1 CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES Beone Medicines I GmbH (CH) 2025-12-10 EP disclosed
US-20250346597-A1 CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES BEONE MEDICINES I GMBH (CH) 2025-11-13 US disclosed
WO-2024160276-A1 CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES BEIGENE, LTD. (KY) 2024-08-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250346597-A1 CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES DGKG, DGKA, DGKK NQO1 2112/4885ALDH1A1 4075/4885MAPT 4168/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.